SMTI dropped the numbers after the close on May 11 — and the print came in ahead of expectations on both the top and bottom lines.
Q1 revenue hit $27.8M, above the $26.8M consensus. EPS of $0.05 beat the $(0.04) estimate by a wide margin. The company held its full-year 2026 sales guidance at $116M–$121M, bracketing the Street's $117.3M estimate, and guided Q2 sales to $28.5M–$29.5M — roughly in line with the $28.65M forecast. This is the profile of a company executing on its turnaround story: core operations now profitable, and growth reaccelerating toward the 13–17% range management has flagged for 2026.
The analyst backdrop reinforces the constructive tone. Both active coverage firms — Lake Street and HC Wainwright & Co. — carry Buy ratings. Lake Street initiated in mid-April at a $32 target, while HC Wainwright has held a $36 target through recent quarters. That puts the consensus mean at $34, against Monday's close of $18.02. The gap is wide, though it reflects the stock's descent from the low-$30s over the past year rather than any fresh bullishness. Bears have pointed to debt levels relative to cash, and operating cash flow that remains thin — but a positive EPS surprise and sustained guidance remove some near-term pressure on those concerns.
The last comparable print, in March 2026, sent the stock down nearly 11% in a single session and left it about 6% lower over the following five days. The context then was different — no comparable beat, no guidance reaffirmation. This time the setup heading into the open is more constructive, though short positioning offers little in the way of squeeze fuel. Short interest runs at just 2.8% of the free float, and has actually edged lower over the past week. Borrow costs are minimal at 0.56% annualised. The lending market is quiet: availability is ample, far below the tight conditions that would suggest any unusual conviction among short sellers. One wrinkle to note: law firms Pomerantz and Schall filed investor-alert notices this week, flagging a fraud investigation — that headline risk had been weighing on the stock alongside the broader 5% pullback on the week.
Ownership is tightly held. Catalyst Rochal controls roughly 28% of shares. Insider activity over recent months has been limited to small executive sells — routine tax-related trades in the $7,500–$17,000 range — with no meaningful net buying or selling in the 90-day window.
The print now tests whether the fraud investigation headlines have been sufficient to fully price in any legal risk, or whether the beat-and-affirm result is enough to shift attention back to the underlying revenue trajectory.
See the live data behind this article on ORTEX.
Open SMTI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
